US20240207261A1

Methods for treating small cell lung cancer and other neuroendocrine cancers

University of Texas System

Abstract

The current disclosure provides novel therapeutic methods for treating SCLC and other neuroendocrine cancers by evaluating the biomarker SLFN 11. Aspects of the disclosure relate to a method for treating a subject with small cell lung cancer (SCLC) or with a neuroendocrine cancer, the method …

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Lauren A. BYERS
Priority date: March 10, 2021
Filing date: March 10, 2022
Publication date: June 27, 2024
Language: en
PDF source: https://patentimages.storage.googleapis.com/52/cb/3b/fa3e6a82fdc97a/US20240207261A1.pdf
Metadata fetched: August 29, 2026 00:32